FOLD FY 2022 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$329M+7.8% YoY

Gross Profit

$291M88.3% margin

Operating Income

-$212M-64.4% margin

Net Income

-$237M-71.9% margin

EPS (Diluted)

$-0.82

Cash Flow

Operating Cash Flow

-$167M

Free Cash Flow

-$170M

Stock-Based Comp.

$77M

Balance Sheet

Total Assets

$724M

Total Liabilities

$601M

Stockholders' Equity

$123M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$329M	$306M	+7.8%
Gross Profit	$291M	$271M	+7.2%
Operating Income	-$212M	-$206M	-2.8%
Net Income	-$237M	-$250M	+5.5%